Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group. Wolfe GI, et al. Among authors: evoli a. Lancet Neurol. 2019 Mar;18(3):259-268. doi: 10.1016/S1474-4422(18)30392-2. Epub 2019 Jan 25. Lancet Neurol. 2019. PMID: 30692052 Free PMC article. Clinical Trial.
Antibodies in myasthenia gravis and related disorders.
Vincent A, McConville J, Farrugia ME, Bowen J, Plested P, Tang T, Evoli A, Matthews I, Sims G, Dalton P, Jacobson L, Polizzi A, Blaes F, Lang B, Beeson D, Willcox N, Newsom-Davis J, Hoch W. Vincent A, et al. Among authors: evoli a. Ann N Y Acad Sci. 2003 Sep;998:324-35. doi: 10.1196/annals.1254.036. Ann N Y Acad Sci. 2003. PMID: 14592891 Review.
Risk factors for tumor occurrence in patients with myasthenia gravis.
Citterio A, Beghi E, Millul A, Evoli A, Mantegazza R, Antozzi C, Baggi F, Cornelio F, Durelli L, Clerico M, Piccolo G, Cosi V. Citterio A, et al. Among authors: evoli a. J Neurol. 2009 Aug;256(8):1221-7. doi: 10.1007/s00415-009-5091-9. Epub 2009 Mar 29. J Neurol. 2009. PMID: 19330280
Immunosuppressive therapies in myasthenia gravis.
Sanders DB, Evoli A. Sanders DB, et al. Among authors: evoli a. Autoimmunity. 2010 Aug;43(5-6):428-35. doi: 10.3109/08916930903518107. Autoimmunity. 2010. PMID: 20166870 Review.
Acquired myasthenia gravis in childhood.
Evoli A. Evoli A. Curr Opin Neurol. 2010 Oct;23(5):536-40. doi: 10.1097/WCO.0b013e32833c32af. Curr Opin Neurol. 2010. PMID: 20581680 Review.
A B3 type-thymoma in a 7-year-old child with myasthenia gravis.
Iorio R, Evoli A, Lauriola L, Batocchi AP. Iorio R, et al. Among authors: evoli a. J Thorac Oncol. 2012 May;7(5):937-8. doi: 10.1097/JTO.0b013e31824cbb18. J Thorac Oncol. 2012. PMID: 22722796 Free article. No abstract available.
205 results